The 13 analysts offering 12-month price forecasts for BioNTech SE have a median target of 207.54, with a high estimate of 324.78 and a low estimate of 148.68. The median estimate represents a +33.94% increase from the last price of 154.95.
The current consensus among 15 polled investment analysts is to Hold stock in BioNTech SE. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $7.40
Reporting Date Mar 29
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.